Modulim Receives 3-year Renewal of ISO-13485 Certification

Irvine, CA—January 7, 2024— Modulim received a three-year renewal of their ISO:13485 certification after a comprehensive review of the company’s quality system, which covers capabilities such as design, manufacturing, and customer management. “Receiving a 3-year renewal highlights the robustness of Modulim’s quality system, and the ability of the team to maintain and scale our processes,” […]

Modulim Granted Patent for a System and Method to Assess Diabetic Circulatory Complications

Irvine, CA—September 22, 2023— Modulim, the leader in point of care microvascular insights, announced the grant of United States Patent US11751769B2, titled “Systems and Methods for Assessing Diabetic Circulatory Complications.” This patent signifies a milestone for Modulim and the relevance of its solutions for diabetes patient management. The patent teaches Modulim’s novel approach to assess […]

New Research Published in the Journal of Surgical Case Reports: “Assessment of Revascularization Impact on Microvascular Oxygenation and Perfusion Using Spatial Frequency Domain Imaging”

Irvine, CA—July 15, 2023— A new clinical case study was published in the Journal of Surgical Case Reports. This research, titled “Assessment of Revascularization Impact on Microvascular Oxygenation and Perfusion Using Spatial Frequency Domain Imaging (SFDI),” sheds light on the potential role of microvascular assessment in lower limb interventional procedures. The study presents representative clinical […]

Modulim Receives US Army Contract to Develop Cutting-Edge Handheld Digital Burn Assessment Tool

Irvine, CA—May 18, 2023— Modulim, the leader in point-of-care microvascular insights, was awarded a 2 year, $2.5M contract from the United States Army Medical Materiel Development Activity (USAMMDA) for the development of a handheld digital burn assessment tool. The proposed solution aims to change the way burn injuries are evaluated and managed, with significant implications […]

New Research Published in the Journal of Diabetes Science and Technology Demonstrates the Ability of Spatial Frequency Domain Imaging (SFDI) to Stratify Severity of Microvascular Disease.

Irvine, CA—February 6, 2023— February 6, 2023 A new peer-reviewed article about Modulim’s technology was recently published in the Journal of Diabetes Science and Technology. The article, entitled “Stratification of Microvascular Disease Severity in the Foot using Spatial Frequency Domain Imaging (SFDI),” was a collaboration between researchers at the University of Arizona and Modulim. The […]

Modulim Announces Intent to Drive Value-Based Care in Nephrology Market With Custom Limb Preservation Solution

Irvine, CA—July 6, 2022— Modulim, a health technology company that delivers point-of-care microvascular and data insights to save limbs and improve lives, announced today that it has launched its Limb Assessment, Management, & Preservation (LAMP) solution to enable accountable care organizations to achieve better outcomes for high-risk Chronic Kidney Disease (CKD) and End-Stage Renal Disease […]

Modulim Featured in Article About Innovation on Main Page of UCI Website

Irvine, CA—July 2021 The UCI Beall Applied Innovation Center recognized Modulim CTO and Founder David Cuccia in a recent article on successful startups. Learn more about how Modulim started and how SFDI technology can be used to innovate healthcare. Link to the article: About Modulim Modulim is a privately held medical device company founded by […]

Case study shows how SFDI measures vascular steal in a post-surgical diabetic foot flap

Irvine, CA—April 1, 2021 Tissue flaps are commonly used in limb salvage to heal wounds and prevent amputations. Patients with advanced peripheral arterial disease (PAD), neurologic function, and diabetes mellitus (DM) often have difficulty with adequate oxygenation and perfusion to the periphery, making the success rates of the flap difficult. This observational case study published […]

Modulim Announces SFDI Technology’s Potential Limb Saving Applications in Research Conducted with Kaiser Permanente

Irvine, CA—February 1, 2021 Modulim, the global leader in optical imaging solutions for the non-invasive assessment of tissue and vascular health, announced today the results from its latest study published in The Journal of Diabetes and Its Complications. Conducted at the podiatry clinic at Kaiser Permanente Southern California, the research evaluated the utility of spatial […]